Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Selenium and vitamin E: interesting biology and dashed hope.

Klein EA.

J Natl Cancer Inst. 2009 Mar 4;101(5):283-5. doi: 10.1093/jnci/djp009. No abstract available.

2.

Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.

Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J.

J Natl Cancer Inst. 2009 Mar 4;101(5):306-20. doi: 10.1093/jnci/djn512.

3.

Re: Selenium and vitamin E: interesting biology and dashed hope.

Goossens ME, Buntinx F, Zeegers MP.

J Natl Cancer Inst. 2009 Oct 7;101(19):1363-4; author reply 1364. doi: 10.1093/jnci/djp272. No abstract available.

4.

Vitamin E in the prevention of prostate cancer: where are we today?

Lee IM, Gaziano JM, Buring JE.

J Natl Cancer Inst. 2006 Feb 15;98(4):225-7. No abstract available.

5.

Re: Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.

Huff J.

J Natl Cancer Inst. 2004 Feb 18;96(4):333-4; author reply 334. No abstract available.

6.

Science peels the onion of selenium effects on prostate carcinogenesis.

Taylor PR, Parnes HL, Lippman SM.

J Natl Cancer Inst. 2004 May 5;96(9):645-7. Review. No abstract available.

7.

StatBite: Physicians' Health Study II randomized controlled trial results.

[No authors listed]

J Natl Cancer Inst. 2009 Apr 1;101(7):447. doi: 10.1093/jnci/djp062. No abstract available.

8.

The negative results of the SELECT study do not necessarily discredit the selenium-cancer prevention hypothesis.

El-Bayoumy K.

Nutr Cancer. 2009;61(3):285-6. doi: 10.1080/01635580902892829. No abstract available.

PMID:
19373601
9.

Randomized trial of aspirin, vitamin E raises questions for future chemoprevention studies.

Hayasaka E.

J Natl Cancer Inst. 2005 Sep 7;97(17):1242-3. No abstract available.

10.

Vitamin E reduces prostate cancer rates in Finnish trial: U.S. considers follow-up.

Smigel K.

J Natl Cancer Inst. 1998 Mar 18;90(6):416-7. No abstract available.

11.

Antioxidants: SELECTed out?

Block KI.

Integr Cancer Ther. 2009 Mar;8(1):5-8. No abstract available.

PMID:
19353756
12.

Re: Fritz H. Schröder, Monique J. Roobol. The REDUCE Trial. Eur Urol 2010;58:253-255.

Cornel EB.

Eur Urol. 2011 Jan;59(1):e1. doi: 10.1016/j.eururo.2010.09.037. No abstract available.

PMID:
20951493
13.

Preventing prostate cancer: new analyses put finasteride back on the map.

Vastag B.

J Natl Cancer Inst. 2008 Aug 20;100(16):1132-3. doi: 10.1093/jnci/djn300. No abstract available.

14.

An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.

Kim ES, Hong WK.

J Natl Cancer Inst. 2005 Apr 6;97(7):468-70. Review. No abstract available.

15.

Increased transglutaminase 2 and GLUT-1 expression in breast tumors not susceptible to chemoprevention with antioxidants.

Martins FC, Teixeira F, Reis I, Geraldes N, Cabrita AM, Dias MF.

Tumori. 2009 Mar-Apr;95(2):227-32.

16.

Selenium, zinc, and prostate cancer.

Platz EA, Helzlsouer KJ.

Epidemiol Rev. 2001;23(1):93-101. Review. No abstract available.

17.

[Prostatic cancers].

Soulié M, Beuzeboc P, Cornud F, Eschwege P, Gaschignard N, Grosclaude P, Hennequin C, Maingon P, Molinié V, Mongiat-Artus P, Moreau JL, Paparel P, Péneau M, Peyromaure M, Ravery V, Rébillard X, Richaud P, Salomon L, Staerman F, Villers A.

Prog Urol. 2007 Nov;17(6):1159-230. French. No abstract available.

PMID:
18153992
18.

The development of vitamin D-based therapies for prostate cancer.

Price N.

Clin Prostate Cancer. 2004 Mar;2(4):202-5. Review. No abstract available.

PMID:
15072600
19.

[Who wants to produce drugs against prostatic cancer?].

Favrbo K.

Ugeskr Laeger. 2005 May 9;167(19):2075-6. Danish. No abstract available.

PMID:
15960469
20.

Dietary tocopherol supplementation after trabeculectomy and phacotrabeculectomy: double-blind randomized placebo-controlled trial.

Goldblum D, Meyenberg A, Mojon D, Tappeiner C, Frueh BE.

Ophthalmologica. 2009;223(4):228-32. doi: 10.1159/000203367.

PMID:
19246952
Items per page

Supplemental Content

Support Center